Diagnosis and management of pituitary tumours in the elderly: A review based on personal experience and evidence of literature

European Journal of Endocrinology

Volumn 153, Issue 6, 2005, Pages 723-735

  Minniti, Giuseppe ^a   Esposito, Vincenzo ^a   Piccirilli, Manolo ^b   Fratticci, Amato ^c   Santoro, Antonio ^b   Jaffrain Rea, Marie Lise ^a,c  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; CORTICOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; KETOCONAZOLE; LEVOTHYROXINE; OCTREOTIDE; PEGVISOMANT; PROLACTIN; SEX HORMONE; SOMATOSTATIN DERIVATIVE; TESTOSTERONE; THYROID HORMONE;

ACROMEGALY; AGED; AGING; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CUSHING DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DOSE RESPONSE; DRUG COST; DRUG DOSE REGIMEN; GROWTH HORMONE RELEASE; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; HYPOPITUITARISM; MALIGNANT NEOPLASTIC DISEASE; NEUROLOGICAL COMPLICATION; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROLACTINOMA; QUALITY OF LIFE; RADIOSURGERY; REVIEW; SIDE EFFECT; STEREOTAXIC SURGERY; TRANSSPHENOIDAL SURGERY; TREATMENT INDICATION; TUMOR LOCALIZATION; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

ACROMEGALY; ADENOMA; AGED; AGING; FEMALE; HORMONE REPLACEMENT THERAPY; HORMONES; HUMANS; HYPOPITUITARISM; MALE; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; PROLACTINOMA; VISION DISORDERS;

EID: 29644443877     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02030     Document Type: Review

References (88)

1. Cohen DL, Bevan JS & Adams CBT. The presentation and management of pituitary tumours in the elderly. Age Ageing 1989 18 247-252.
2. Puchner MJA, Knappe UJ & Ludecke DK. Pituitary surgery in elderly patients with acromegaly. Neurosurgery 1995 36 677-684.
3. Fraioli B, Pastore FS, Signoretti S, De Caro GMF & Giuffrè R. The surgical treatment of pituitary adenomas in the eigth decade. Surgical Neurology 1999 51 261-267.
4. Turner HE, Adams CBT & Wass JAH. Pituitary tumours in the elderly: a 20-year experience. European Journal of Endocrinology 1999 140 383-389.
5. Kurosaki M, Ludecke DK, Flitsch J & Saeger W. Surgical treatment of clinically non-secreting pituitary adenomas in elderly patients. Neurosurgery 2000 47 843-849.
6. Benbow SJ, Foy P, Jones B, Shaw D & McFarlane IA. Pituitary tumours presenting in the elderly: management and outcome. Clinical Endocrinology (Oxford) 1997 46 657-660.
7. Ferrante L, Trillo G, Ramundo E, Celli P, Jaffrain-Rea ML, Salvati M, Esposito V, Roperto R, Osti MF & Minniti G. Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up. Journal of Neuro-Oncology 2002 60 185-191.
8. Pospiech J, Stolke D & Pospiech FR. Surgical treatment of pituitary adenomas in the elderly. Acta Neurochirurgica Supplement (Wien) 1996 65 35-36.
9. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Moroni C, Lenzi J, Tamburrano G, Cassone R & Cantore G. Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients. Acta Neurochirurgica (Wien) 2001 143 1205-1211.
10. Turner HE & Wass JAH. Pituitary tumours in the elderly. Baillière's Clinical Endocrinology & Metabolism 1997 11 407-422.
11. Losa M. Pituitary tumors in the elderly. European Journal of Endocrinology 1999 140 378-380.
12. Young WF Jr, Scheithauer BW, Kovacs KT, Horvath E, Davis DH & Randall RV. Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases. Mayo Clinic Proceedings 1996 71 649-656.
13. Ho MD, Hsu CY, Ting LT & Chiang H. The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases. Human Pathology 1997 28 905-911.
14. Jaffrain-Rea ML, Di Stefano D, Minniti G, Esposito V, Bultrini A, Ferretti E, Santoro A, Faticanti Scucchi L, Gulino A & Cantore G. A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas. Endocrine-Related Cancer 2002 9 103-113.
15. Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F, Mortini P & Giovanelli M. Proliferation index in non-functioning pituitary adenomas: clinical characteristics and long-term follow-up. Neurosurgery 2000 47 1313-1318.
16. Zikel OM, Atkinson JLD & Hurley DL. Prolactinoma manifesting with symptomatic hydrocephalus. Mayo Clinic Proceedings 1999 74 475-477.
17. Saeed S, Farooqi OA, Panayiotou B & Harvey TC. Reversible confusional state in an elderly man. Postgraduate Medical Journal 1999 75 365-366.
18. Iglesias P, Macho LP & Diez JJ. Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy. Age Ageing 2004 33 410-412.
19. Kovacs K, Ryan N, Horvath E, Singer W & Ezrin C. Pituitary adenomas in old age. Journal of Gerontology 1980 35 16-22.
20. Biousse V, Newman NJ & Oyesiku NM. Precipitating factors in pituitary apoplexy. Journal of Neurology Neurosurgery and Psychiatry 2001 71 542-545.
21. Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, Sakas DE & Thalassinos NC. Tumors metastatic to the pituitary gland: case report and literature review. Journal of Clinical Endocrinology and Metabolism 2004 89 574-580.
22. Tayal SC, Bansal SK & Chadha DK. Hypopituitarism: a difficult diagnosis in elderly people but worth a search. Age Ageing 1999 23 320-322.
23. Diederich S, Franzen NF, Bahr V & Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Journal of Endocrinology 2003 148 609-617.
24. Chanson P. Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age. European Journal of Endocrinology 2003 149 177-188.
25. Delgrange E, Maiter D, Donckier J & Tourniaire J. Influence of age on the clinical presentation of prolactinomas in male patients. Gerontology 1999 45 160-164.
26. Molitch ME. Evaluation and treatment of the patient with a pituitary incidentaloma. Journal of Clinical Endocrinology and Metabolism 1995 80 3-6.
27. Armstrong P & Charlesworth M. Imaging of the pituitary and hypothalamus. In Clinical Endocrine Oncology, pp 158-167. Eds R Sheaves, PJ Jenkins & JA Wass. Oxford: Blackwell Science, 1997.
28. Lamberts SWJ, van den Beld AW & van der Lely AJ. The endocrinology of aging. Science 1997 278 419-424.
29. Blackman MR. Pituitary hormones and aging. Endocrinology and Metabolism Clinics 1987 16 981-994.
30. Kaufman JM & Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005 26 833-876.
31. Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, Fioravanti M, Cuzzoni G, Pontiggia B & Magri F. Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. European Journal of Endocrinology 2001 144 319-329.
32. St-Jean E, Blain F & Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clinical Endocrinology (Oxford) 1996 44 305-309.
33. Grottoli S, Razzore P, Gaia D, Gasperi M, Giusti M, Colao A, Ciccarelli E, Gasco V, Martino E, Ghigo E & Camanni F. Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. Journal of Endocrinological Investigation 2003 26 123-127.
34. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A & Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602.
35. Ghigo E, Aimaretti G, Corneli G, Bellone J, Arvat E, Maccario M & Camanni F. Diagnosis of GH deficiency in adults. Growth Hormone and IGF-I Research 1998 8 S55-S58.
36. Abs R. Update on the diagnosis of GH deficiency in adults. European Journal of Endocrinology 2003 148 S3-S8.
37. Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G & Beck-Peccoz P. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1999 84 924-929.
38. Wartofsky L & Burman KD. Alterations in thyroid function in patients with systemic illness: the 'euthyroid sick syndrome'. Endocrine Reviews 1982 3 164-217.
39. Mariotti S, Franceschi C, Cossarizza A & Pinchera A. The aging thyroid. Endocrine Reviews 1995 16 686-715.
40. Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, Papalia A, Casini MR & Loche S. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. European Journal of Endocrinology 2005 152 735-741.
41. Valenti G. Adrenopause: an imbalance between dehydroepiandrostenedione (DHEAS) and cortisol secretion. Journal of Endocrinological Investigation 2002 25 (10 Suppl) 29-35.
42. American Society of Anesthesiologists, New classification of physical status. Anesthesiology 1963 24 111.
43. Ciric I, Ragin A, Baumgartner C & Pierce D. Complications of transsphenoidal surgery: result of a national survey, review of the literature and personal experience. Neurosurgery 1997 40 225-237.
44. Barker FG, Klibanski A & Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. Journal of Clinical Endocrinology and Metabolism 2003 88 4709-4719.
45. Cappabianca P & De Divitiis E. Endoscopy and transsphenoidal surgery. Neurosurgery 2004 54 1043-1048.
46. Arafah BM. Reversible hypopituitarism in patients with large non-functioning pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1986 62 1173-1179.
47. Bradley KM, Adams CB, Potter CP, Wheeler DW, Anslow PJ & Burke CW. An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clinical Endocrinology (Oxford) 1994 41 655-659.
48. Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK & Ridgway EC. Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 1998 43 432-438.
49. Woollons AC, Hunn MK, Rajapakse YR, Hamilton DA, Conaglen JV & Balakrishnan V. Non-functioning pituitary adenomas: indications for postoperative radiotherapy. Clinical Endocrinology (Oxford) 2000 53 713-717.
50. Turner HE, Stratton IM, Byrne JV, Adams CB & Wass JA. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clinical Endocrinology (Oxford) 1999 51 281-284.
51. Feldkamp J, Santen R, Harms E, Aulich A, Modder U & Scherbaum WA. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas-results of a prospective study. Clinical Endocrinology (Oxford) 1999 51 109-113.
52. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K & Melmed S. Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529.
53. Seidman PA, Kofke WA, Policare R & Young M. Anesthetic complications of acromegaly. British Journal of Anaesthesia 2000 84 179-182.
54. Ben-Shlomo A & Melmed S. The role of pharmacotherpay in perioperative management of patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2003 88 963-968.
55. Colao A, Ferone D, Cappabianca P, Del Basso De Caro ML, Marzullo P, Monticelli A, Alfieri A, Merola B, Cali A, de Divitiis E & Lombardi G. Effect of octreotide pretreatment on surgical outcome in acromegaly. Journal of Clinical Endocrinology and Metabolism 1997 82 3308-3314.
56. Bochicchio D, Losa M Buchfelder M & the European Cushing's Disease Survey Study Group, Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. Journal of Clinical Endocrinology and Metabolism 1995 80 3114-3120.
57. Liu JK & Couldwell WT. Contemporary management of prolactinomas. Neurosurgical Focus 2004 16 E2.
58. Molitch ME, Thorner MO & Wilson CB. Management of prolactinomas: overview and introduction. Journal of Clinical Endocrinology and Metabolism 1997 82 996-1000.
59. Karunakaran S, Page RC & Wass JA. The effect of menopause on prolactin levels in patients with hyperprolactinemia. Clinical Endocrinology (Oxford) 2001 54 295-300.
60. Baldelli R, Ferretti E, Jaffrain-Rea ML, Minniti G, Iacobellis G, Gulino A & Tamburano G. Cardiac effects of SR-Lanreotide, a slow-release somatostatin analog, in acromegalic patients. Journal of Clinical Endocrinology and Metabolism 1999 84 527-532.
61. Amato G, Mazziotti G, Rotondi M, Iorio S, Doga M, Sorvillo F, Manganella G, Di Salle F, Giustina A & Carella C. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Clinical Endocrinology (Oxford) 2002 56 65-71.
62. Freda PU. How effective are current therapies for acromegaly? Growth Hormone & IGF Research 2003 13 S144-S151.
63. Van der Lely AJ, Harris AG & Lamberts SWJ. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: Influence of age and sex. Clinical Endocrinology (Oxford) 1992 37 181-185.
64. Didoni G, Grottoli S, Gasco V, Battistini M, Ferone D, Giusti M, Ragazzoni F, Ruffo P, Ghigo E & Minuto F. Cost-of-illness study in acromegalic patients in Italy. Journal of Endocrinological Investigation 2004 27 1034-1039.
65. Baldelli R, Battista C, Leonetti F, Ghiggi MR, Ribaudo MC, Paoloni A, D'Amico E, Ferretti E, Baratta R, Liuzzi A, Trischitta V & Tamburrano G. Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment. Clinical Endocrinology (Oxford) 2003 59 492-499.
66. Clayton RN. Cardiovascular function in acromegaly. Endocrine Reviews 2003 24 272-277.
67. Petrossians P, Borges-Martin L, Espinoza C, Daly A, Betea D, Valdes Socin H, Stevenaert A, Chanson P & Beckers A. Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. European Journal of Endocrinology 2005 152 61-66.
68. Trainer PJ. Lessons from 6 years of GH receptor antagonis therapy for acromegaly. Journal of Endocrinological Investigation 2003 26 (Suppl 10) 44-52.
69. Heaney AP. Novel medical approaches for the treatment of Cushing's disease. Journal of Endocrinological Investigation 2004 27 591-595.
70. van Schaardenburg D, Roelfsema F, van Seters AP & Vielvoye GJ. Bromocriptine therapy for non-functioning pituitary adenoma. Clinical Endocrinology (Oxford) 1989 30 475-484.
71. Gasperi M, Petrini L, Pilosu R, Nardi M, Marcello A, Mastio F, Bartalena L & Martino E. Octreotide treatment does not affect the size of most non-functioning pituitary adenomas. Journal of Endocrinological Investigation 1993 16 541-543.
72. Andersen M, Bjerre P, Schroder HD, Edal A, Hoilund-Carlsen PF, Pedersen PH & Hagen C. In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas. Clinical Endocrinology (Oxford) 2001 54 23-30.
73. Laurberg P, Andersen S, Bulow Pedersen I & Carle A. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging 2005 22 23-38.
74. Whitehead MI. Royal College of Obstetricians and Gynaecologists study group on menopause and HRT. RCOG, Recommendations on hormone replacement therapy. Lancet 2005 365 749.
75. American Society for Reproductive Medicine (ASRM), Practice Committee. Treatment of androgen deficiency in the aging male. Fertility and Sterility 2004 81 1437-1440.
76. Snyder PJ. Hypogonadism in elderly men - what to do until evidence comes. New England Journal of Medicine 2004 350 440-442.
77. Feldt-Rasmussen U, Wilton P Jonsson P & KIMS Study Group & KIMS International Board, Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults. Growth Hormone & IGF Research 2004 14 S51-S58.
78. Monson JP & Jonsson P. Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS. Hormone Research 2000 60 S112-S120.
79. Jerome J, Shiry L & Leyland-Jones B. Deregulation of the IGF-I axis in cancer: epidemiological evidence and potential therapeutic interventions. Endocrine-Related Cancer 2003 10 561-578.
80. Colao A, Di Somma C, Spiezia S, Filipella M, Pivonello R & Lombardi G. Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients. Journal of Clinical Endocrinology and Metabolism 2003 88 88-94.
81. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S & Uttley D. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clinical Endocrinology (Oxford) 1993 38 571-578.
82. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP & Bertherat J. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. Journal of Clinical Endocrinology and Metabolism 2000 85 3779-3785.
83. Minniti G, Jaffrain-Rea ML, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G & Enrici RM. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clinical Endocrinology (Oxford) 2005 62 210-216.
84. Brada M, Ashley S, Ford D, Traish D, Burchell L & Rajan B. Cerebrovascular mortality in patients with pituitary adenoma. Clinical Endocrinology (Oxford) 2002 57 713-717.
85. Erfurth EM, Bulow B, Svahn-Tapper G, Norrving B, Odh K, Mikoczy Z, Bjork J & Hagmar L. Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. Journal of Clinical Endocrinology and Metabolism 2002 87 4892-4899.
86. Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T & Barcelo B. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. New England Journal of Medicine 1997 336 172-177.
87. Brada M, Ajithkumar TV & Minniti G. Radiosurgery for pituitary adenomas. Clinical Endocrinology (Oxford) 2004 61 531-543.
88. Jalali R, Brada M, Perks JR, Warrington AP, Traish D, Burchelle L, McNair H, Thomas DGT, Robinson S & Johnston DG. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience. Clinical Endocrinology (Oxford) 2000 52 695-702.